Answers are grounded in this paper and cite their sources.
Crystallographic analysis reveals the atomic structures and dehydration dynamics of fludarabine phosphate forms, highlighting pathways for solid-state drug stability.
Fludarabine (9-β-d-arabinofuranosyl-2-fluoroadenine) is a purine analogue used for the treatment of various types of lymphoid malignancies. It is administered in its phosphate form; however, ts crystal structure has not been reported previously. In this work, we present the structural determination of two solid forms of fludarabine phosphate: Form I (hydrate) and Form II (anhydrate). The structures were elucidated using a combination of X-ray powder diffraction, DFT computations, solid-state NMR and TGA/DSC experiments. In addition, we discuss the preferred protonation state and the dehydration process of the investigated phases.
No takes yet. Share an insight, caveat, or question.
Hušák et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: